MX2013009007A - Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas. - Google Patents
Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas.Info
- Publication number
- MX2013009007A MX2013009007A MX2013009007A MX2013009007A MX2013009007A MX 2013009007 A MX2013009007 A MX 2013009007A MX 2013009007 A MX2013009007 A MX 2013009007A MX 2013009007 A MX2013009007 A MX 2013009007A MX 2013009007 A MX2013009007 A MX 2013009007A
- Authority
- MX
- Mexico
- Prior art keywords
- nutritional compositions
- protein
- omega
- methods
- make
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pediatric Medicine (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Child & Adolescent Psychology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161438804P | 2011-02-02 | 2011-02-02 | |
| PCT/US2012/022726 WO2012106179A1 (en) | 2011-02-02 | 2012-01-26 | High protein nutritional compositions and methods of making and using same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2013009007A true MX2013009007A (es) | 2013-08-29 |
Family
ID=45554910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013009007A MX2013009007A (es) | 2011-02-02 | 2012-01-26 | Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9930908B2 (enExample) |
| EP (1) | EP2670262B2 (enExample) |
| JP (1) | JP6034805B2 (enExample) |
| CN (1) | CN103347403B (enExample) |
| AU (3) | AU2012212591A1 (enExample) |
| BR (1) | BR112013019677B1 (enExample) |
| CA (1) | CA2824591C (enExample) |
| ES (1) | ES2882806T3 (enExample) |
| MX (1) | MX2013009007A (enExample) |
| PH (1) | PH12013501433A1 (enExample) |
| RU (1) | RU2013140443A (enExample) |
| SG (1) | SG191428A1 (enExample) |
| WO (1) | WO2012106179A1 (enExample) |
| ZA (1) | ZA201306543B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112013019677B1 (pt) | 2011-02-02 | 2019-10-08 | Société des Produits Nestlé S.A. | Uso de proteína compreendendo pelo menos 30% do total da energia da composição nutricional e de uma proporção de ácidos graxos ômega-6 e ômega-3 |
| US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
| MX2015011771A (es) | 2013-03-08 | 2016-12-07 | Axiom Foods Inc | Suplemento de proteínas de arroz y métodos de uso de este. |
| EP3082465A2 (en) * | 2013-12-19 | 2016-10-26 | Abbott Laboratories | Nutritional composition comprising hydrolyzed protein |
| CN105212042A (zh) * | 2014-06-30 | 2016-01-06 | 罗汉斐 | 一种小麦发酵营养食品及其制作方法 |
| WO2018209131A1 (en) | 2017-05-12 | 2018-11-15 | Axiom Foods, Inc. | Rice products and systems and methods for making thereof |
| US10806169B2 (en) | 2018-05-15 | 2020-10-20 | Kate Farms, Inc. | Hydrolyzed pea protein-based nutrient composition |
| US20190374569A1 (en) * | 2018-06-12 | 2019-12-12 | Richard Laver | Intact pea protein-based nutrient composition |
| CA3099923A1 (en) * | 2018-06-14 | 2019-12-19 | Mars, Incorporated | Composition for supporting animal with cancer |
| US11058139B2 (en) * | 2018-07-03 | 2021-07-13 | Kerri Ann Langhorne | Recovery supplement for horses |
| JP7682790B2 (ja) | 2018-11-20 | 2025-05-26 | フォンテラ コ－オペレイティブ グループ リミティド | 乳製品およびプロセス |
| FR3093427B1 (fr) * | 2019-03-05 | 2021-03-05 | Mativa Tech | Composition pour son utilisation dans la prévention et/ou le traitement de la dysbiose |
| AU2020284169A1 (en) * | 2019-05-31 | 2021-10-28 | Societe Des Produits Nestle Sa | MCT-based nutrition blend for providing health benefits in animals |
| AR120346A1 (es) * | 2019-10-31 | 2022-02-09 | Idemitsu Kosan Co | Agente para suprimir la resistencia a la insulina en rumiantes |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6140304A (en) | 1988-09-28 | 2000-10-31 | Eicotech Corporation | Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia |
| US5714472A (en) | 1993-12-23 | 1998-02-03 | Nestec Ltd. | Enternal formulation designed for optimized nutrient absorption and wound healing |
| DE69525150T2 (de) | 1994-04-01 | 2002-09-05 | Abbott Laboratories, Abbott Park | Nahrungsprodukt zur behandlung der ulzerativen kolitis sowie verwendung desselben |
| US5776913A (en) | 1995-10-10 | 1998-07-07 | Colgate Palmolive Company | Therapeutic diet for metabolic abnormalities found in animals with lymphoma |
| AU759641B2 (en) | 1998-08-19 | 2003-04-17 | Skyepharma Canada Inc. | Injectable aqueous dispersions of propofol |
| US20040121044A1 (en) * | 2001-03-14 | 2004-06-24 | John Tiano | Nutritional product with high protein, low carbohydrate content and good physical stability |
| US20030055023A1 (en) * | 2001-03-20 | 2003-03-20 | Rajewski Roger A. | Formulations containing etomidate and a sulfoalkyl ether cyclodextrin |
| SE526943C2 (sv) | 2002-08-26 | 2005-11-22 | Indevex Ab | Födoämneskompositionsprodukt |
| US20040225022A1 (en) | 2003-05-09 | 2004-11-11 | Desai Neil P. | Propofol formulation containing reduced oil and surfactants |
| JP4699901B2 (ja) * | 2003-09-02 | 2011-06-15 | ジェレックスインターナショナル株式会社 | 体脂肪代謝機能と燃焼エネルギーの活用機能とを備えているダイエット用添加物質 |
| US7759507B2 (en) * | 2003-09-05 | 2010-07-20 | Abbott Laboratories | Lipid system and methods of use |
| EP1723951A1 (en) | 2005-04-21 | 2006-11-22 | N.V. Nutricia | Nutritional supplement with oligosaccharides for a category of HIV patients |
| EP1771091B1 (en) * | 2004-07-01 | 2017-11-08 | Nestec S.A. | Canine osteoarthritis diet formulation |
| KR101075816B1 (ko) * | 2004-09-22 | 2011-10-25 | 아지노모토 가부시키가이샤 | 종합 경장 영양 조성물 |
| MX2008002701A (es) | 2005-08-26 | 2008-03-18 | Nestec Sa | Nutricion para pacientes obesos. |
| US20070166411A1 (en) * | 2005-12-16 | 2007-07-19 | Bristol-Myers Squibb Company | Nutritional supplement containing long-chain polyunsaturated fatty acids |
| EP1971230A2 (en) | 2006-01-09 | 2008-09-24 | Nestec S.A. | Treatment of stressed patients |
| BRPI0621481A2 (pt) * | 2006-03-23 | 2011-12-13 | Nestec Sa | suplemento nutricional de alta caloria |
| GB0612671D0 (en) | 2006-06-27 | 2006-08-09 | Shs Int Ltd | Nutritional formulation |
| PT2374452T (pt) | 2008-12-05 | 2019-10-31 | Ajinomoto Kk | Composição de nutrientes |
| BR112013019677B1 (pt) | 2011-02-02 | 2019-10-08 | Société des Produits Nestlé S.A. | Uso de proteína compreendendo pelo menos 30% do total da energia da composição nutricional e de uma proporção de ácidos graxos ômega-6 e ômega-3 |
-
2012
- 2012-01-26 BR BR112013019677-7A patent/BR112013019677B1/pt active IP Right Grant
- 2012-01-26 MX MX2013009007A patent/MX2013009007A/es not_active Application Discontinuation
- 2012-01-26 WO PCT/US2012/022726 patent/WO2012106179A1/en not_active Ceased
- 2012-01-26 RU RU2013140443/13A patent/RU2013140443A/ru not_active Application Discontinuation
- 2012-01-26 PH PH1/2013/501433A patent/PH12013501433A1/en unknown
- 2012-01-26 ES ES12701664T patent/ES2882806T3/es active Active
- 2012-01-26 US US13/982,822 patent/US9930908B2/en active Active
- 2012-01-26 AU AU2012212591A patent/AU2012212591A1/en not_active Abandoned
- 2012-01-26 EP EP12701664.0A patent/EP2670262B2/en active Active
- 2012-01-26 JP JP2013552560A patent/JP6034805B2/ja active Active
- 2012-01-26 CN CN201280007307.3A patent/CN103347403B/zh active Active
- 2012-01-26 CA CA2824591A patent/CA2824591C/en active Active
- 2012-01-26 SG SG2013051719A patent/SG191428A1/en unknown
-
2013
- 2013-08-30 ZA ZA2013/06543A patent/ZA201306543B/en unknown
-
2016
- 2016-03-01 AU AU2016201327A patent/AU2016201327A1/en not_active Abandoned
-
2017
- 2017-09-05 AU AU2017225011A patent/AU2017225011B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2013140443A (ru) | 2015-03-10 |
| US9930908B2 (en) | 2018-04-03 |
| BR112013019677A2 (pt) | 2017-03-21 |
| BR112013019677B1 (pt) | 2019-10-08 |
| CN103347403B (zh) | 2016-04-20 |
| CA2824591C (en) | 2019-02-05 |
| ZA201306543B (en) | 2015-03-25 |
| US20140308390A1 (en) | 2014-10-16 |
| ES2882806T3 (es) | 2021-12-02 |
| AU2017225011A1 (en) | 2017-09-28 |
| AU2016201327A1 (en) | 2016-03-17 |
| EP2670262B1 (en) | 2021-06-30 |
| EP2670262B2 (en) | 2025-10-15 |
| WO2012106179A1 (en) | 2012-08-09 |
| CA2824591A1 (en) | 2012-08-09 |
| CN103347403A (zh) | 2013-10-09 |
| AU2017225011B2 (en) | 2019-07-18 |
| JP2014505702A (ja) | 2014-03-06 |
| PH12013501433A1 (en) | 2013-09-09 |
| SG191428A1 (en) | 2013-08-30 |
| EP2670262A1 (en) | 2013-12-11 |
| AU2012212591A1 (en) | 2013-07-25 |
| JP6034805B2 (ja) | 2016-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2013009007A (es) | Composiciones nutricionales altas en proteina y metodos para elaborar y utilizar las mismas. | |
| CO2021003893A2 (es) | Formulaciones para mejorar la salud intestinal | |
| CL2018002997A1 (es) | Compuestos medicinales y suplementos nutricionales de base vegetal de rápida acción. | |
| DOP2014000159A (es) | Composiciones enriquecidas con dpa de ácidos grasos omega 3 poliinsaturados en forma de ácido libre | |
| MX2021004999A (es) | Administracion de butirato, beta-hidroxibutirato, cannabidiol y compuestos relacionaods en seres humanos. | |
| PE20151864A1 (es) | Composiciones nutricionales que contienen una fraccion enriquecida de lipido y usos del mismo | |
| MX356184B (es) | Fórmulación pediátrica sintética que comprende un probiótico. | |
| EA201991289A1 (ru) | Быстродействующие лекарственные соединения и пищевые добавки растительного происхождения | |
| AR104835A1 (es) | Composiciones nutricionales que contienen un nivel elevado de inositol y uso de las mismas | |
| AR088205A1 (es) | Composiciones nutricionales fitonutrientes | |
| JP2014505702A5 (enExample) | ||
| NZ600167A (en) | Concentrated therapeutic phospholipid compositions | |
| AR097110A1 (es) | Composiciones nutricionales que contienen una combinación sinérgica y usos de las mismas | |
| AR105237A1 (es) | Método y composiciones nutricionales que contienen fosfatidiletanolamina, esfingomielina y ácido docosahexaenoico | |
| AR105144A1 (es) | Composiciones nutricionales y métodos para promover el desarrollo cognitivo | |
| MX2019009952A (es) | Formulaciones de evolocumab de baja viscosidad y alta concentracion y metodos de elaboracion de las mismas. | |
| PH12018500090A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
| AR110060A1 (es) | Composiciones nutricionales que proporcionan el manejo dietético de cólicos | |
| AR100313A1 (es) | Composiciones nutricionales dirigidas a sujetos con alergias a la proteína de la leche de vaca | |
| CL2018003537A1 (es) | Lípidos con un número impar de átomos de carbono y su uso como una composición farmacéutica o como un suplemento nutricional. | |
| MX2016000187A (es) | Composiciones y metodos para mejorar el rendimiento del ejercicio. | |
| CO7310519A2 (es) | Enriquecedor para un sucedáneo de la leche materna | |
| PE20141192A1 (es) | Metodo para la inhibicion de patogenos usando una composicion nutricional | |
| AR096564A1 (es) | Composiciones nutricionales para bebés prematuros | |
| MX2016011025A (es) | Composiciones de grapiprant y metodos para usar las mismas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |